Cleared Traditional

K880545 - STIMWEAR GARMENTS, SIGNAL I AND SIGNAL II

K880545 is an FDA 510(k) clearance for STIMWEAR GARMENTS, manufactured by Stimwear. The device is a Class 2 Neurology device with product code GXY cleared through the Traditional 510(k) pathway after a 112-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 1988
Decision
112d
Days
Class 2
Risk

K880545 is an FDA 510(k) clearance for the STIMWEAR GARMENTS, SIGNAL I AND SIGNAL II. Classified as Electrode, Cutaneous (product code GXY), Class II - Special Controls.

Submitted by Stimwear (Lakewood, US). The FDA issued a Cleared decision on May 31, 1988 after a review of 112 days - within the typical 510(k) review window.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.1320 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all Stimwear devices

FDA 510(k) Submission Details - K880545

510(k) Number K880545 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 09, 1988
Decision Date May 31, 1988
Days to Decision 112 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
36d faster than avg
Panel avg: 148d · This submission: 112d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GXY Device Classification - Class 2, Special Controls

Product Code GXY Electrode, Cutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.1320
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GXY Electrode, Cutaneous

All 318
Devices cleared under the same product code (GXY) and FDA review panel - the closest regulatory comparables to K880545.
STRAIGHT-LINE FINISH FOR IMPLANTABLE PULSE GENERA.
K881749 · Medtronic Vascular · Jul 1988
SPARE MS 700 TENS ELECTRODE
K881871 · Lectec Corp. · Jun 1988
TENS ELECTRODE MODEL 238P
K881872 · Lectec Corp. · Jun 1988
TENS ELECTRODE SNAP TYPE, DISPOSA., SELF-ADHERING
K880649 · Labeltape Meditect, Inc. · Mar 1988
MEDTRONIC SNAP EASE MODEL 7795 CUTANEOUS ELECTRODE
K875284 · Medtronic Vascular · Jan 1988
LECTEC STIMULATING ELECTRODE
K872250 · Lectec Corp. · Aug 1987